tramiprosate has been researched along with Peripheral Nerve Diseases in 1 studies
tramiprosate: GABA receptor agonist and a glycosaminoglycan mimetic; has nootropic acitivity; structure; a sulfonate analog of GABA
3-aminopropanesulfonic acid : An amino sulfonic acid that is the 3-amino derivative of propanesulfonic acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fragai, M | 1 |
| Comito, G | 1 |
| Di Cesare Mannelli, L | 1 |
| Gualdani, R | 1 |
| Calderone, V | 1 |
| Louka, A | 1 |
| Richichi, B | 1 |
| Francesconi, O | 1 |
| Angeli, A | 1 |
| Nocentini, A | 1 |
| Gratteri, P | 1 |
| Chiarugi, P | 1 |
| Ghelardini, C | 1 |
| Tadini-Buoninsegni, F | 1 |
| Supuran, CT | 1 |
| Nativi, C | 1 |
1 other study available for tramiprosate and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Lipoyl-Homotaurine Derivative (ADM_12) Reverts Oxaliplatin-Induced Neuropathy and Reduces Cancer Cells Malignancy by Inhibiting Carbonic Anhydrase IX (CAIX).
Topics: Antineoplastic Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Cell Line, Tumor; Drug | 2017 |